TRESIBA FLEXTOUCH (100 UNITS/ML INSULIN DEGLUDEC) – SYSTEMIC ULTRA-LONG-ACTING BASAL INSULIN STABILIZATION THERAPY

Tresiba is a high-precision, pharmaceutical-grade ultra-long-acting insulin (Insulin Degludec) engineered for the clinical management of Type 1 and Type 2 Diabetes Mellitus. It works through a sophisticated molecular mechanism: after subcutaneous injection, the degludec molecules form a systemic "multi-hexamer" chain in the fatty tissue. These chains slowly and systemically release individual insulin molecules into the bloodstream at a remarkably constant rate. This action effectively provides a stable clinical profile for up to 42 hours, clearing high fasting sugar and significantly reducing the systemic risk of nocturnal hypoglycemia in the high-stress Nigerian environment.

In Nigeria, Tresiba is a premier clinical choice for patients who require the most stable systemic "foundation" currently available in insulin therapy. It is particularly valued for its "Flexible Dosing" profile; while it should be taken daily, its long systemic half-life means that if a dose is delayed by a few hours, the risk of a sugar spike is much lower than with older insulins. At Sanlive Pharmacy, we ensure our Tresiba stock is stored in strictly climate-controlled cold-chain environments ($2°C$ to $8°C$) to maintain the molecular stability of the insulin degludec. This is critical because advanced insulins are highly thermosensitive; exposure to the intense Nigerian sun or high-temperature storage in non-pharmacy environments can cause the protein to denature, significantly reducing the product's ability to clear your sugar and increasing the risk of systemic hyperglycemia.

Important: This is a potent systemic hormonal therapy.

• The "Cold-Chain" Rule: You must keep your unopened Tresiba pens in the refrigerator; once a pen is "in-use," it can be kept at room temperature (below 30°C) for up to 56 days (8 weeks), providing the longest systemic "shelf-life" for an opened pen in the Nigerian healthcare landscape.

• The "FlexTouch" Benefit: You should be aware that the FlexTouch pen does not "extend" as you dial the dose; this makes it much easier for patients with localized hand weakness or arthritis to press the button for a full systemic dose.

• The "Hypoglycemia" Note: You must always carry a systemic "fast-acting" sugar source; although Tresiba has the lowest systemic risk of "sugar lows," you must still be prepared to treat a drop to prevent fainting in the Nigerian climate.

Key Uses & Benefits

• Ultra-Long Basal Glucose Control: Effectively stabilizing systemic blood sugar for over 42 hours.

• Nighttime Hypoglycemia Reduction: Providing the lowest systemic risk of "midnight" sugar crashes.

• Flexible Dosing Window: Allowing for systemic stability even if your daily timing varies slightly.

• Type 1 and Type 2 Diabetes Management: Providing the most advanced clinical anchor for therapy.

• FlexTouch Pen Precision: Ensuring accurate systemic dosing with a low-force injection button.

• 8-Week In-Use Stability: Providing a clinical solution for patients who travel within Nigeria.

• Targeted Glycemic Reset: Providing a clinical solution for long-term HbA1c reduction.

Who Should Use This Product?

• Adults and children (1 year and older) suffering from clinically diagnosed diabetes.

• Individuals requiring a proactive, systemic basal insulin solution with the lowest risk of "lows."

Not recommended for: The treatment of diabetic ketoacidosis (DKA). It is strictly contraindicated for individuals during systemic episodes of hypoglycemia. Consult our pharmacist if the patient is pregnant. Consult your doctor immediately if you experience localized "severe rash" or systemic "shortness of breath," as these require professional clinical investigation for hormonal stability in the Nigerian healthcare landscape.

Suggested Clinical Usage

• Administered via the Subcutaneous (SC) Route, typically injected once daily.

• The "Administration" Tip: Inject into the systemic fatty tissue of the abdomen, thigh, or upper arm; rotate your localized injection sites every day to prevent lumpy skin (Lipohypertrophy).

• The "8-Hour" Rule: If you miss your systemic dose, take it as soon as you remember, but ensure there are at least 8 hours between doses to avoid a localized buildup of insulin.

• Consistency is Vital: To effectively manage your sugar, try to take Tresiba at the same time every day; consistent systemic levels lead to the best clinical outcomes.

• The "Storage" Tip: Keep unopened pens in the fridge; never freeze Tresiba, as the Nigerian "ice block" effect will destroy the systemic insulin molecules immediately.

Common Side Effects

• Systemic Hypoglycemia: A common reaction if a meal is missed, though less frequent than with Lantus.

• Localized Injection Site Reaction: A temporary redness or itching where the needle entered.

• Mild Weight Gain: Occasionally occurring as the body begins to process sugar correctly.

• Rare but serious: Severe Allergic Reaction—discontinue use if you feel systemic "wheezing."

• Rare: Occasional localized skin thickening (Lipodystrophy) if sites are not rotated.

Seek medical advice immediately if you experience persistent confusion, localized tremors, or signs of a severe allergic reaction.

Manufacturer

Novo Nordisk – Ensuring Tresiba FlexTouch meets international gold standards for insulin efficacy and molecular purity.

Why Buy from Sanlive Pharmacy?

• 100% Authentic: Guaranteed original Novo Nordisk stock with verified batch numbers and secure NAFDAC registration.

• Cold-Chain Protection: Our professional medical refrigeration ensures the insulin remains active despite the Nigerian heat.

• Professional Guidance: Access to licensed pharmacists for clinical counseling on Injection Technique and Managing Sugar Lows.

• Reliable Delivery: Fast and secure shipping across Nigeria, ensuring your essential life-support arrives in perfect, factory-sealed condition.

FAQs

Is it "Better" than Lantus or Levemir?

Systemically, Tresiba is more advanced. It lasts much longer and has a "flatter" systemic profile. Clinical studies show it causes significantly fewer nighttime "sugar lows" compared to Lantus, which is a major benefit for many Nigerian patients.

Can I take it at "Any Time" of the day?

Yes, as long as you take it once every day. If you usually take it in the morning but forget and take it in the evening, Tresiba’s ultra-long systemic action will keep you protected. Just ensure there are 8 hours before your next systemic dose.

How long does the pen stay "Good" outside the fridge?

Tresiba has a systemic advantage here. While Lantus and Levemir last 28-42 days, a Tresiba pen is systemically stable at room temperature for 56 days (8 weeks). This is perfect for Nigerians who may have inconsistent electricity for their refrigerators.

Where can I purchase this in Nigeria?

You can find verified, correctly stored Tresiba FlexTouch at Sanlive Pharmacy & Stores with a valid medical prescription for guaranteed product integrity and professional diabetic health support.

Order Tresiba FlexTouch from Sanlive Pharmacy with fast delivery nationwide.